PT97996A - Processo para a preparacao de uma formulacao radiofarmaceutica compreendendo pelo menos um radionuclideo - Google Patents

Processo para a preparacao de uma formulacao radiofarmaceutica compreendendo pelo menos um radionuclideo

Info

Publication number
PT97996A
PT97996A PT97996A PT9799691A PT97996A PT 97996 A PT97996 A PT 97996A PT 97996 A PT97996 A PT 97996A PT 9799691 A PT9799691 A PT 9799691A PT 97996 A PT97996 A PT 97996A
Authority
PT
Portugal
Prior art keywords
radionuclideo
radiofarmaceutical
comprehending
preparing
formula
Prior art date
Application number
PT97996A
Other languages
English (en)
Other versions
PT97996B (pt
Inventor
Jaime Simon
Joseph R Garlich
R Keith Frank
Kenneth Mcmillan
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of PT97996A publication Critical patent/PT97996A/pt
Publication of PT97996B publication Critical patent/PT97996B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
PT97996A 1990-06-18 1991-06-17 Processo para a preparacao de uma formulacao radiofarmaceutica compreendendo pelo menos um radionuclideo PT97996B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53887190A 1990-06-18 1990-06-18

Publications (2)

Publication Number Publication Date
PT97996A true PT97996A (pt) 1992-03-31
PT97996B PT97996B (pt) 1998-11-30

Family

ID=24148781

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97996A PT97996B (pt) 1990-06-18 1991-06-17 Processo para a preparacao de uma formulacao radiofarmaceutica compreendendo pelo menos um radionuclideo

Country Status (32)

Country Link
US (1) US5762907A (pt)
EP (1) EP0462787B1 (pt)
JP (2) JP3636728B2 (pt)
KR (1) KR100219964B1 (pt)
CN (1) CN1033143C (pt)
AT (1) ATE123955T1 (pt)
AU (2) AU651112B2 (pt)
BR (2) BR9102579A (pt)
CA (1) CA2044812C (pt)
CS (1) CS184291A3 (pt)
CY (1) CY1891A (pt)
DE (1) DE69110554T2 (pt)
DK (1) DK0462787T3 (pt)
EG (1) EG19862A (pt)
ES (1) ES2073678T3 (pt)
FI (1) FI101044B (pt)
GR (1) GR3017430T3 (pt)
HK (1) HK80496A (pt)
HU (1) HU226897B1 (pt)
IE (1) IE71023B1 (pt)
IL (1) IL98536A (pt)
IS (1) IS1704B (pt)
MC (1) MC2260A1 (pt)
NO (1) NO302510B1 (pt)
NZ (1) NZ238547A (pt)
PH (1) PH30975A (pt)
PL (1) PL165699B1 (pt)
PT (1) PT97996B (pt)
RU (1) RU2095085C1 (pt)
SA (1) SA92120343B1 (pt)
SK (1) SK279598B6 (pt)
ZA (1) ZA914615B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5410043A (en) * 1991-12-06 1995-04-25 Schering Aktiengesellschaft Process for the production of mono-N-substituted tetraaza macrocycles
US5320829A (en) * 1991-12-10 1994-06-14 The Dow Chemical Company Oral compositions for inhibiting plaque formation
DE4218744C2 (de) * 1992-06-04 1997-11-06 Schering Ag Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe
US5405601A (en) * 1993-07-02 1995-04-11 Mallinckrodt Medical Inc. Functionalized tripodal ligands for imaging applications
CN1065769C (zh) * 1997-07-03 2001-05-16 中国原子能科学研究院 一种放射性药物制剂的制备方法
CN1092962C (zh) * 1998-01-26 2002-10-23 贾伟 一种减轻骨及骨关节疾病疼痛的药物
EP1191948A2 (en) * 1999-06-11 2002-04-03 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
WO2002062398A2 (en) 2001-01-08 2002-08-15 Neorx Corporation Radioactively labelled conjugates of phosphonates
US6567492B2 (en) 2001-06-11 2003-05-20 Eastern Isotopes, Inc. Process and apparatus for production of F-18 fluoride
US7018614B2 (en) * 2002-11-05 2006-03-28 Eastern Isotopes, Inc. Stabilization of radiopharmaceuticals labeled with 18-F
BR0215913A (pt) 2002-11-05 2005-08-09 Ion Beam Applic Sa Composição de radiofármacos rotulados com 18-f e processo para obtê-los
TWI610685B (zh) * 2013-05-13 2018-01-11 視界全球控股有限公司 用於癌症標靶治療及診斷成像之包含經修飾的基於血紅素之治療劑的醫藥組成物
PL3054996T3 (pl) * 2013-10-07 2023-09-18 Igl Pharma, Inc. Sposób wytwarzania wysoce czystych środków do leczenia kości
EP3226884B1 (en) * 2014-12-04 2021-02-17 GE Healthcare Limited Method of removing acetaldehyde from radioactive pharmaceuticals
RU2593017C1 (ru) * 2015-04-23 2016-07-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Способ получения радиофармацевтического препарата "астат-211"
ES2844623T3 (es) 2015-05-21 2021-07-22 Actinium Pharmaceueuticals Inc Administración de infusión de anticuerpos monoclonales conjugados
EP3302496B1 (en) * 2015-05-25 2021-01-06 IGL Pharma, Inc. Dotmp kit formulations for radioisotopes
US11369700B2 (en) * 2015-05-25 2022-06-28 IGL Pharma Inc. DOTMP kit formulations for radioisotopes
RU2757258C1 (ru) * 2020-09-28 2021-10-12 федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский ядерный университет "МИФИ" (НИЯУ МИФИ) Способ получения радиофармацевтического препарата с галлием-68 для визуализации метастазов скелета методом пэт

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018883A (en) * 1975-03-10 1977-04-19 Nichols Institute For Endocrinology Thyroxine (T4) radioimmunoassay
NL7605447A (nl) * 1975-06-26 1976-12-28 Byk Mallinckrodt Chem Prod Radioimmunoproefmethode voor de bepaling van thyroxine.
US4301140A (en) * 1979-12-14 1981-11-17 G. D. Searle & Co. Radiopharmaceutical method for monitoring kidneys
US4341755A (en) * 1980-07-15 1982-07-27 Immuno Nuclear Corporation Parathyroid radioimmunoassay
US4457602A (en) * 1981-04-20 1984-07-03 Olympus Optical Company Ltd. Multiple light emission control system utilizing electronic flashes
US4411881A (en) * 1982-07-12 1983-10-25 New England Nuclear Corporation Composition and method for stabilizing radiolabeled compounds using thiocarbonylated diethylenetriamines
DE164843T1 (de) * 1984-06-04 1989-12-07 The Dow Chemical Co., Midland, Mich. Organische aminphosphonsaeurekomplexe fuer die behandlung von verkalkenden tumoren.
US4898724A (en) * 1984-06-04 1990-02-06 The Dow Chemical Company Organis amine phosphonic acid complexes for the treatment of calcific tumors
US5059412A (en) * 1984-06-04 1991-10-22 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors
US5064633A (en) * 1984-06-04 1991-11-12 The Dow Chemical Company Macrocyclic aminophosphonic acid complexes, their formulations and use
GB8510726D0 (en) * 1985-04-26 1985-06-26 Amersham Int Plc Stabilised radio-labelled compounds
US4752464A (en) * 1985-06-07 1988-06-21 Cadema Medical Products, Inc. Treatment of arthritis, including rheumatoid arthritis, with radioactive isotopes
NZ222304A (en) * 1987-05-18 1990-10-26 Dow Chemical Co Suppression of bone marrow using samarium-153, gadolinium-159 or holmium-166 complexes
US4853209A (en) * 1987-05-18 1989-08-01 The Dow Chemical Company Bone marrow suppressing agents
WO1989000052A1 (en) * 1987-06-30 1989-01-12 Mallinckrodt, Inc. Method for enhancing the safety of metal-ligand chelates as magnetic resonants imaging agents and x-ray contrast agents
US4882142A (en) * 1988-12-19 1989-11-21 The Dow Chemical Company Bone marrow suppressing agents
US4937333A (en) * 1989-08-04 1990-06-26 The Dow Chemical Company Method for purifying aminomethylenephosphonic acids for pharmaceutical use
US5219556A (en) * 1990-07-09 1993-06-15 Mallinckrodt Medical, Inc. Stabilized therapeutic radiopharmaceutical complexes

Also Published As

Publication number Publication date
IS3717A7 (is) 1991-12-19
JP3636728B2 (ja) 2005-04-06
RU2095085C1 (ru) 1997-11-10
NO302510B1 (no) 1998-03-16
ES2073678T3 (es) 1995-08-16
FI101044B (fi) 1998-04-15
BR9102579A (pt) 1992-01-21
KR100219964B1 (ko) 1999-09-01
IS1704B (is) 1998-12-10
EP0462787A1 (en) 1991-12-27
FI912933A (fi) 1991-12-19
US5762907A (en) 1998-06-09
ATE123955T1 (de) 1995-07-15
EP0462787B1 (en) 1995-06-21
GR3017430T3 (en) 1995-12-31
NZ238547A (en) 1994-05-26
IL98536A0 (en) 1992-07-15
HU912011D0 (en) 1991-12-30
PT97996B (pt) 1998-11-30
NO912345D0 (no) 1991-06-17
JP2002114712A (ja) 2002-04-16
PL290717A1 (en) 1992-02-24
MC2260A1 (fr) 1993-04-26
FI912933A0 (fi) 1991-06-17
HK80496A (en) 1996-05-17
EG19862A (en) 1996-06-30
JPH04230224A (ja) 1992-08-19
IE71023B1 (en) 1997-01-15
PH30975A (en) 1997-12-23
CN1033143C (zh) 1996-10-30
HU226897B1 (en) 2010-01-28
DE69110554D1 (de) 1995-07-27
AU7847091A (en) 1991-12-19
KR920000334A (ko) 1992-01-29
IL98536A (en) 1996-10-31
AU665911B2 (en) 1996-01-18
IE912057A1 (en) 1991-12-18
CS184291A3 (en) 1992-02-19
BR1101169A (pt) 2000-08-08
CN1063615A (zh) 1992-08-19
SA92120343B1 (ar) 2004-01-25
ZA914615B (en) 1993-02-24
NO912345L (no) 1991-12-19
DK0462787T3 (da) 1995-10-30
DE69110554T2 (de) 1995-12-14
PL165699B1 (pl) 1995-01-31
CA2044812C (en) 2002-12-31
SK279598B6 (sk) 1999-01-11
AU651112B2 (en) 1994-07-14
CY1891A (en) 1996-08-30
CA2044812A1 (en) 1991-12-19
AU6455994A (en) 1994-08-04
HUT57994A (en) 1992-01-28

Similar Documents

Publication Publication Date Title
PT97996A (pt) Processo para a preparacao de uma formulacao radiofarmaceutica compreendendo pelo menos um radionuclideo
DE3267039D1 (en) Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle
BR9503936A (pt) Composoto seu uso; composição farmacêutica; processo para a complexação com um radionuclídio do dito composto e combinação terapêutica
IE790652L (en) Imidazole derivatives
IL66943A (en) Compositions containing substituted hydroxy-malonic acid diamides and their use for combating insects and acarids
NO883520L (no) Fremgangsmaate for fremstilling av et injeksjonspreparat.
EP0446921A3 (en) Optically active alkylene-dioxybenzene derivatives and their use in therapy
MX169381B (es) Polimeros de poliacrilato que emplean retardador de urea substituido
AU557798B2 (en) Radiographic imaging composition
KR920007680A (ko) 분말의 응집 방지방법
ATE36957T1 (de) N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
ES464729A1 (es) Un procedimiento para la preparacion de benzisotiazolonas amino-alquil sustituidas.
GR81392B (pt)
DK228480A (da) Fremgangsmaade til fremstilling af basisk substituerede phenoler samt salte isaer pharmaceutisk anvendelige ikke-toksiske syreadditionssalte af saadanne forbindelser
AR241499A1 (es) Procedimiento para preparar compuesto de 1-(2 o 5-nitro-1-imidazolil)-3-aziridin-propanol-2 o 4-aziridin-2-propanol o aziridin 2,3-butanodiol.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19911216

FG3A Patent granted, date of granting

Effective date: 19980824

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20100224